Inflammation & Cardiovascular Risk Panel

An evidence-based inflammation and cardiovascular risk panel measuring high-sensitivity CRP, Lipoprotein(a), Apolipoprotein levels, uric acid, and homocysteine — with GP-led interpretation and personalised cardiovascular risk management.

Regis Medical's inflammation and cardiovascular risk panel goes beyond standard cholesterol testing to assess the underlying inflammatory drivers of heart disease, metabolic syndrome, and chronic illness. The centrepiece inflammation marker is High-Sensitivity C-Reactive Protein (hs-CRP), a sensitive indicator of systemic inflammation strongly linked to cardiovascular risk, atherosclerosis progression, and chronic disease activity. hs-CRP is included in Regis Medical's broader cardiovascular screening packages and provides a more nuanced picture than standard CRP in low-risk populations. Lipoprotein(a) and Apolipoprotein A1/B testing (SGD 120) is available for advanced lipid risk stratification, as Lp(a) is a genetically determined independent cardiovascular risk factor not captured by standard lipid panels. A standard Lipid Panel (SGD 30) covers LDL, HDL, total cholesterol, and triglycerides, forming the baseline cardiovascular assessment. Uric Acid testing (SGD 15) assesses gout risk and is also an emerging inflammatory biomarker associated with cardiovascular and metabolic disease. Homocysteine testing is available via the clinic's general blood test menu as a cardiovascular and neurological risk marker. The Heart Screening Test page indicates the clinic offers comprehensive cardiac assessment including 12-Lead ECG (SGD 30), Treadmill Stress ECG (SGD 300), and Treadmill Stress Echocardiogram (SGD 700) for functional cardiac assessment in higher-risk patients. Arthritis and autoimmune inflammatory markers including Rheumatoid Factor and other panels are available. All inflammation panel results are reviewed by a GP in a personalised consultation with cardiovascular risk scoring, lifestyle recommendations, and pharmacological management where indicated.